APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations

Experimental Cell Research

Volumn 287, Issue 1, 2003, Pages 1-9

  Bergman, Anna ^a   Religa, Dorota ^a   Karlström, Helena ^a   Laudon, Hanna ^a   Winblad, Bengt ^a   Lannfelt, Lars ^b   Lundkvist, Johan ^a   Näslund, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

AICD; Alzheimer's disease; Amyloid peptide; RIP; Secretase; Cleavage

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ENZYME INHIBITOR; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; L 685458; LUCIFERASE; PRESENILIN; PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL MEMBRANE; CHIMERA; CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM; FAMILIAL DISEASE; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 0037530133     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00117-4     Document Type: Article

References (43)

1. Selkoe D.J. Alzheimer's disease genes, proteins, and therapy . Physiol. Rev. 81:2001;741-766.
2. Esler W.P., Wolfe M.S. A portrait of Alzheimer secretases- new features and familiar faces. Science. 293:2001;1449-1454.
3. Sisodia S.S., St George-Hyslop P. γ-Secretase, Notch, Aβ, and Alzheimer's disease where do the presenilins fit in? Nature Rev. Neurosci. 3:2001;281-290.
4. Brown M.S., Ye J., Rawson R.B., Goldstein J.L. Regulated intramembrane proteolysis a control mechanism conserved from bacteria to humans . Cell. 100:2000;391-398.
5. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1998;518-522.
6. Marambaud P., Shioi J., Serban G., Georgakopolous A., Sarner S., Nagy V., Baki L., Wen P., Efthiomopoulos S., Shao Z., Wisniewski T., Robakis N.K. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21:2002;1948-1956.
7. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A.J., Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155:2001;755-762.
8. Lammich S., Okochi M., Takeda M., Kaether C., Capell A., Zimmer A.-K., Edbauer D., Walter J., Steiner H., Haass C. Presenilin dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide. J. Biol. Chem. 277:2002;44754-44759.
9. Ni C.-Y., Murphy M.P., Golde T.E., Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science. 294:2001;2179-2181.
10. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
11. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature. 398:1999;513-517.
12. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.-Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.-S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Liang Y., Zhang D.M., Aebersold R., Farrer L., Sorbi S., Bruni A., Fraser P., St George-Hyslop P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature. 407:2000;48-54.
13. Goutte C., Tsunozaki M., Hale V., Priess J.R. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in C. elegans embryos. Proc. Natl. Acad. Sci. USA. 99:2002;775-779.
14. Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., Curtis D. aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev. Cell. 3:2002;85-97.
15. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
16. Jarrett J.T., Lansbury P.T. Jr. Seeding "one-dimensional crystallization" of amyloid a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
17. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Ab monoclonals evidence that an initially deposited species is Aβ42(43) . Neuron. 13:1994;45-53.
18. Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M.M., Teplow D.B., Haass C. Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2:2001;835-841.
19. Weidemann A., Eggert S., Reinhard F.B.M., Vogel M., Paliga K., Baier G., Masters C.L., Beyreuther K., Evin G. A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry. 41:2002;2825-2835.
20. Yu C., Kim S.-H., Ikeuchi T., Xu H., Gasparini L., Wang R., Sisodia S.S. Characterization of a presenilin-mediated amyloid precursor carboxyl-terminal fragment γ J. Biol. Chem. 276:2001;43756-43760.
21. Chen F., Gu Y., Hasegawa H., Ruan X., Arawaka S., Fraser P., Westaway D., Mount H., St George-Hyslop P. Presenilin 1 mutations activate Aβ42 secretase but reciprocally inhibit ε-secretase cleavage of APP and S3-cleavage of Notch. J. Biol. Chem. 277:2002;36521-36526.
22. Ebino J.O., Yankner B.A. A RIP tide in neuronal signal transduction. Neuron. 34:2002;499-502.
23. Cao X., Südhof T.C. A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 293:2001;115-120.
24. Karlström H., Bergman A., Lendahl U., Näslund J., Lundkvist J. A sensitive and quantitative assay for measuring cleavage of presenilin substrates. J. Biol. Chem. 277:2002;6763-6766.
25. Taniguchi Y., Karlström H., Lundkvist J., Mizutani T., Otaka A., Vestling M., Bernstein A., Donoviel D., Lendahl U., Honjo T. Notch receptor cleavage depends on but is not directly executed by presenilins. Proc. Natl. Acad. Sci. USA. 99:2002;4014-4019.
26. Donoviel D.B., Hadjantonakis A.-K., Ikeda M., Zheng H., St George-Hyslop P., Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Devel. 13:1999;2801-2810.
27. Näslund J., Haroutunian V., Mohs R.C., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283:2000;1571-1577.
28. Shearman M.S., Beher D., Clarke E.E., Lewis H.D., Harrison T., Hunt P., Nadin A., Smith A.L., Stevenson G., Castro J.L. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity. Biochemistry. 39:2000;8698-8704.
29. Dovey H.F., John V., Anderson J.P., Chen Z., de Saint Andrieu P., Fang L.Y., Freedman S.B., Folmer B., Goldbach E., Holsztynska J., Hu K.L., Johnson-Wood K., Kennedy S.L., Kholodenko D., Knops J.E., Latimer L.H., Lee M., Liao Z., Lieberburg I.M., Motter R.N., Mutter L.C., Nietz J., Quinn K.P., Sacchi K.L., Seubert P.A., Shopp G.M., Thorsett E.D., Tung J.S., Wu J., Yang S., Yin C.T., Schenk D.B., May P.C., Altstiel L.D., Bender M.H., Bogas L.N., Britton T.C., Clemens J.C., Czilli D.L., Dieckman-McGinty D.K., Droste J.J., Fuson K.S., Gitter B.D., Hyslop P.A., Johnstone E.M., Li W.-Y., Little S.P., Mabry T.E., Miller F.D., Ni B., Nissen J.S., Porter W.J., Potts B.D., Reel J.K., Stephenson D., Su Y., Shipley L.A., Whitesitt C.A., Yin T., Audia J.E. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76:2001;173-181.
30. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 398:1998;382-386.
31. Maltese W.A., Wilson S., Tan Y., Suomensaari S., Sinha S., Barbour R., McConlogue L. Retention of the Alzheimer's amyloid precursor fragment C99 in the endoplasmic reticulum prevents formation of amyloid β-peptide. J. Biol. Chem. 276:2001;20267-20279.
32. Wilson C.A., Doms R.W., Zheng H., Lee V.M.-Y. Presenilins are not required for Aβ42 production in the early secretory compartment. Nature Neurosci. 5:2002;849-855.
33. 42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease. Hum. Mol. Genet. 9:2000;2589-2598.
34. Eckman C.B., Mehta N.D., Crook R., Perez-tur J., Prihar G., Pfeiffer E., Graff-Radford N., Hinder P., Yager D., Zenk B., Refolo L.M., Prada C.M., Younkin S.G., Hutton M., Hardy J. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42(43). Hum. Mol. Genet. 6:1997;2087-2089.
35. Kimberley W.T., Zheng J.B., Guenette S.Y., Selkoe D.J. The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner. J. Biol. Chem. 276:2001;40288-40292.
36. Cupers P., Orlans I., Craessaerts K., Annaert W., De Strooper B. The amyloid precursor protein (APP)-cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78:2001;1168-1178.
37. Kinochita A., Whelan C.M., Smith C.J., Berezovska O., Hyman B.T. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein association with Fe65 and translocation to the nucleus . J. Neurochem. 82:2002;839-847.
38. Leissring M., Murphy M.P., Mead T.R., Akbari Y., Sugarman M.C., Jannatipour M., Anliker B., Muller U., Saftig P., De Strooper B., Wolfe M.S., Golde T.E., LaFerla F. A physiologic signaling role for the γ- secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA. 99:2002;4697-4702.
39. Moehlmann T., Winkler E., Xia X., Edbauer D., Murrell J., Capell A., Kaether C., Zheng H., Ghetti B., Haass C., Steiner H. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production. Proc. Natl. Acad. Sci. USA. 99:2002;8025-8030.
40. Neve R.L., McPhie D.L., Chen Y. Alzheimer's disease a dysfunction of the amyloid precursor protein . Brain Res. 886:2000;54-66.
41. Okamoto I., Takeda S., Giambarella U., Murayama Y., Matsui T., Katada T., Matsuura Y., Nishimoto I. Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. EMBO J. 15:1996;3769-3777.
42. Okochi M., Steiner H., Fukumori A., Tanii H., Tomita T., Tanaka T., Iwatsubo T., Kudo T., Takeda M., Haass C. Presenilins mediate a dual intramembranous γ-secretase cleavage of Notch-1. EMBO J. 21:2002;5408-5416.
43. Petit A., Bihel F., Alves da Costa C., Pourquie O., Checler F., Kraus J.-L. New protese inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nature Cell Biol. 3:2001;507-511.